Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

(2016) Robert M. Berman et al.   CNS SPECTRUMS

Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System

(2014) Douglas L. Leslie et al.   PSYCHIATRIC SERVICES

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

(2013) Jelena Savović et al.   ANNALS OF INTERNAL MEDICINE

Use of Antipsychotics Among Older Residents in VA Nursing Homes

(2012) Walid F. Gellad et al.   MEDICAL CARE

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

(2012) Maurizio Fava et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published Literature to the US Food and Drug Administration Database

(2012) Erick H. Turner et al.   PLOS MEDICINE

Symptomatic and Functional Improvement in Employed Depressed Patients

(2011) Boadie W. Dunlop et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

(2011) G. C. Alexander et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Quality of Life: The Ultimate Outcome Measure of Interventions in Major Depressive Disorder

(2011) Waguih William IsHak et al.   HARVARD REVIEW OF PSYCHIATRY

Assuring That Double-Blind Is Blind

(2010) Roy H. Perlis et al.   AMERICAN JOURNAL OF PSYCHIATRY

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

(2010) Nizar El-Khalili et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder

(2010) Michael Bauer et al.   JOURNAL OF AFFECTIVE DISORDERS

Underrecognition of Clinically Significant Side Effects in Depressed Outpatients

(2010) Mark Zimmerman et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder

(2010) John Zajecka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

(2010) Kenneth F. Schulz et al.   PLOS MEDICINE

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

National Patterns in Antidepressant Medication Treatment

(2009) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder

(2009) Hollis Reeves et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Unclear Clinical Significance of Findings in Adjunctive Aripiprazole for Major Depressive Disorder

(2009) Alexander C. Tsai   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Aripiprazole in Refractory Depression?

(2009) Bernard J. Carroll   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

(2009) Karen Hewett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

(2008) Richard C. Shelton et al.   ACTA PSYCHIATRICA SCANDINAVICA

Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials

(2008) D. Deshauer et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

(2008) Gabor I. Keitner et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

(2008) K Hewett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

(2008) Erick H. Turner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias

(2008) Kerry Dwan et al.   PLoS One

Efficacy of antidepressants

(2008) Erick H Turner et al.   BMJ-British Medical Journal

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

(2008) Irving Kirsch et al.   PLOS MEDICINE